Newleos Therapeutics Debuts with $93.5 Million Oversubscribed Series A Financing to Transform the Treatment of Neuropsychiatric Disorders through the Advancement of Novel Medicines Business Wire Nawigacja wpisu U.S. investors, Big Pharma race to find new medicines in China – CNBC AI in medicine—a threat to patient autonomy? – Medical Xpress
